Evidence map›Paper›PMID 12514204›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2003

Subunit-specific modulation of KCNQ potassium channels by Src tyrosine kinase.

Nikita Gamper, James D Stockand, Mark S Shapiro

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 102 citations in OpenAlex.

  1. Article
  2. Gain of function due to increased opening probability by twoProceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  3. Article
  4. KJournal of neurophysiology · 2021
    Article
  5. Kv7 Channels and Excitability Disorders.Handbook of experimental pharmacology · 2021
    Article
  6. Article
  7. Review
  8. KFrontiers in cellular neuroscience · 2020
    Review
  9. The Role of KFrontiers in physiology · 2020
    Review
  10. Article
  11. The KThe Journal of physiology · 2019
    Article
  12. Restoration of Kv7 Channel-Mediated Inhibition Reduces Cued-Reinstatement of Cocaine Seeking.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2018
    Article
  13. The Kv7 Channel and Cardiovascular Risk Factors.Frontiers in cardiovascular medicine · 2017
    Review
  14. Noise-induced hearing loss: Neuropathic pain via Ntrk1 signaling.Molecular and cellular neurosciences · 2016
    Article
  15. Rescue of homeostatic regulation of striatal excitability and locomotor activity in a mouse model of Huntington's disease.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  16. PP2 prevents β-adrenergic stimulation of cardiac pacemaker activity.Journal of cardiovascular pharmacology · 2014
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 2 countries.

Nikita GamperDepartment of Physiology, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229, USA.
James D Stockand
Mark S Shapiro
The University of Texas Health Science Center at San Antonio · US

Funding

Modulation of Neuronal Ion Channels by 2nd MessengersR01NS043394 · NINDS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI SHAPIRO, MARK S · 2002 to 2014
$4.5M
NINDS NIH HHS NS43394NINDS NIH HHS R01 NS043394
6 · The paper itself

Abstract

We studied regulation by c-Src tyrosine kinase (Src) of KCNQ1-5 channels heterologously expressed in Chinese hamster ovary (CHO) cells and of native M current in rat sympathetic neurons. Using whole-cell patch clamp, we found that Src modulates currents from KCNQ3, KCNQ4, and KCNQ5 homomultimers, KCNQ2/3 heteromultimers and native M current, but not currents from KCNQ1 or KCNQ2 homomultimers. Src overexpression had two effects: a decrease of current amplitude (4- to 15-fold for cloned channels and approximately 3-fold for M current) and a slowing of activation kinetics by 2-fold. Both Src actions were mostly reversed by bath application of the Src inhibitors erbstatin (20 microm) and PP2 (200 nm), and mimicked by the tyrosine phosphatase inhibitor sodium vanadate (100 microm). Immunoprecipitation and immunoblot analysis showed Src-dependent phosphotyrosine signals associated with KCNQ3, KCNQ4, and KCNQ5 but not with KCNQ1 or KCNQ2 that may be tyrosine phosphorylation of the channel subunits. Expression of a dominant negative Src that cannot phosphorylate substrates had no effect on the current and did not induce phosphotyrosine signals associated with KCNQ3-5 subunits, further indicating that Src actions on KCNQ currents are mediated by tyrosine phosphorylation. Immunostaining and confocal analysis showed no effect of Src overexpression on the abundance of KCNQ3 protein in CHO cells. Finally, experiments using cloned KCNQ2/3 channels, Src and M(1) muscarinic receptors, and sympathetic neurons demonstrated that the actions on KCNQ channels by Src and by muscarinic agonists use distinct mechanisms.

Indexed as

AnimalsCells, CulturedCHO CellsCricetinaeElectric ConductivityEnzyme InhibitorsKCNQ2 Potassium ChannelKCNQ3 Potassium ChannelKineticsMuscarinic AgonistsMutationNeuronsPatch-Clamp TechniquesPhosphorylationPotassium ChannelsPotassium Channels, Voltage-GatedEnzyme InhibitorsKCNQ2 Potassium ChannelKcnq2 protein, ratKCNQ3 Potassium ChannelKcnq3 protein, ratMuscarinic AgonistsPotassium ChannelsPotassium Channels, Voltage-GatedProtein SubunitsProto-Oncogene Proteins pp60(c-src)TyrosineVanadates

Identifiers

PMID12514204
PMCPMC6742119
OpenAlexW2145102240

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.